Home > Accelerator platforms > CellAnalytics Platform

ANALYTICS is critical : Cellanalytics Platform is the Solution

Cellanalytics Platform : the Origin

ATMP is not a simple Biologics, it’s a “living drug” that must be stringently controlled before being administered to patients.

The more characterized the cell product, the safer for administration to patient is.

 

That’s why at Cell-Easy we have decided to focus on the analytics aspecty of your ATMP and set up an evolutive, customizable and predictive Platform that should allow the characterization not only the Safety of the product but also its therapeutic potential.

 

          • Cellnature Card

 

          • Cellsecure Card

 

          • Cellfeature Card

 

IDENTITY

SAFETY

THERAPEUTIC

PERFORMANCE

 

As a Drug Developer, you are the owner of your future ATMP clinical success..

 

As an expert CDMO player, we are the right Partner to unveil critical quality parameters of your Product, resulting in full-compliant and safer products for patients.

 

ANALYTICS at a glance

 

 

 

Cell Purity

0-100%

Proliferative Capacity

0-100%

Clonogenicity

0-100%

Oxydative stress resistance

0-100%

Oriented-differentiation capacities

0-100%

Customizables ATMP Identity Assays

Sterility Microbial

Yes/No

Mycrobacteria

Yes/No

Mycoplasm

Yes/No

Endotoxin

Yes/No

Virology status

Yes/No

Pro-coagulant activity

0-100%

Genetic stability

0-100%

Tumorogenicity

Yes/No

Senescence

0-100%

Viability

0-100%

Customizables ATMP Safety Control

Immuno-modulatory Profile

Pro/Anti

Inflammatory Profile

Pro/Anti

Angiogenic Profile

Pro/Anti

Cytotoxic Activity

0-100%

Anti-tumoral Activity

0-100%

Metabolic Assays

Migration Assay

Customizables ATMP Potency Assays

Contact

  • Tel : +33 534 276 550
  • Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
  • Mail : info@cell-easy.com
European leading CDMO company specialized in large volume industrialized production of GMP approved cell products